Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-05-21

Clinical Trial Update: Exparel as a Nerve Block for Severe Hand Pain [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial of Exparel (liposomal bupivacaine) as a nerve block for severe hand pain in CREST syndrome and peripheral vascular disease was terminated; resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Exparel (liposomal bupivacaine)

Snippet

Sponsor: Jose Soberon, MD | Conditions: CREST Syndrome, Peripheral Vascular Disease | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2024-05-21